The Technical Field "因子" had 932 patent application filings in the most recent period (2022-01-01 to 2022-08-31). This is a significantly decreased of -630 filings (-40.3%) over 1,562 they had in the same period of the previous year (2021-01-01 to 2021-08-31). This report also includes technical terms related to " ファクタ ", " ファクター " in the search set.
The highest number of filings in 2017 with 3,163 cases, and their lowest number in 2022 with 1,052 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 11,616 cases in total) is 1,936, and the median is 2,336. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
Index | Value |
---|---|
Average | 1,936 patents |
Std Dev | 1,020 |
COV | 0.5 |
Year | Cases | YOY |
---|---|---|
2022 year | 1,052 cases | -54.2 % |
2021 year | 2,298 cases | -3.20 % |
2020 year | 2,374 cases | -14.82 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 因子 for the period of the last 10 years (2014-01-01 to 2024-04-30). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 因子, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
The changes in the number of patent filings of 因子 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
This patent analysis report was created for a patent search set of 23,744 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 因子 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Comparing the number of applications of each company, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 10 cases, followed by 株式会社日立製作所 with 9 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 10 cases |
株式会社日立製作所 | 9 cases |
ジェネンテックインコーポレイテッド | 8 cases |
ノバルティスアーゲー | 7 cases |
エフホフマン-ラロシュアーゲー | 5 cases |
東レ株式会社 | 4 cases |
コーニンクレッカフィリップスエヌヴェ | 4 cases |
株式会社東芝 | 3 cases |
クゥアルコム・インコーポレイテッド | 2 cases |
武田薬品工業株式会社 | 2 cases |
Comparing the number of applications of each company, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last for the target period (2014 to 2024) with 238 cases, followed by ジェネンテックインコーポレイテッド with 220 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 238 cases |
ジェネンテックインコーポレイテッド | 220 cases |
ノバルティスアーゲー | 163 cases |
エフホフマン-ラロシュアーゲー | 130 cases |
コーニンクレッカフィリップスエヌヴェ | 116 cases |
武田薬品工業株式会社 | 101 cases |
クゥアルコム・インコーポレイテッド | 98 cases |
株式会社日立製作所 | 97 cases |
東レ株式会社 | 64 cases |
株式会社東芝 | 52 cases |
パナソニックホールディングス株式会社 | 2 cases |
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 因子 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Among the top coapplicants, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 10 cases, followed by 株式会社日立製作所 with 9 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 10 cases |
株式会社日立製作所 | 9 cases |
ジェネンテックインコーポレイテッド | 8 cases |
ノバルティスアーゲー | 7 cases |
東レ株式会社 | 4 cases |
コーニンクレッカフィリップスエヌヴェ | 4 cases |
株式会社東芝 | 3 cases |
Among the top coapplicants, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last for the target period (2014 to 2024) with 238 cases, followed by ジェネンテックインコーポレイテッド with 220 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 238 cases |
ジェネンテックインコーポレイテッド | 220 cases |
ノバルティスアーゲー | 163 cases |
コーニンクレッカフィリップスエヌヴェ | 116 cases |
株式会社日立製作所 | 97 cases |
東レ株式会社 | 64 cases |
株式会社東芝 | 52 cases |
Below is a ranking of the number of JP patent applications by 因子’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 因子’s top 7 coapplicants over the last 20 years.
因子 filed 220 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 80 cases in total) is 13.3, and the median is 13.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 40 cases, and their lowest number in 2022 with 8 cases.
Index | Value |
---|---|
Average | 13.3 patents |
Std Dev | 7.9 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 8 cases | -63.6 % |
2021 year | 22 cases | +69.2 % |
2020 year | 13 cases | -43.5 % |
因子 filed 97 joint applications with 株式会社日立製作所 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 51 cases in total) is 8.5, and the median is 9.5. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2021 with 14 cases, and their lowest number in 2020 with 8 cases.
Index | Value |
---|---|
Average | 8.5 patents |
Std Dev | 4.2 |
COV | 0.5 |
Year | Cases | YOY |
---|---|---|
2022 year | 9 cases | -35.7 % |
2021 year | 14 cases | +75.0 % |
2020 year | 8 cases | -20.00 % |
因子 filed 238 joint applications with ザリージェンツオブザユニバーシティオブカリフォルニア for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 130 cases in total) is 21.7, and the median is 23.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2018 with 42 cases, and their lowest number in 2022 with 10 cases.
Index | Value |
---|---|
Average | 21.7 patents |
Std Dev | 13.6 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 10 cases | -56.5 % |
2021 year | 23 cases | -25.81 % |
2020 year | 31 cases | +29.17 % |
因子 filed 64 joint applications with 東レ株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 29 cases in total) is 4.8, and the median is 5.0. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2014 with 10 cases, and their lowest number in 2021 with 2 cases.
Index | Value |
---|---|
Average | 4.8 patents |
Std Dev | 3.3 |
COV | 0.7 |
Year | Cases | YOY |
---|---|---|
2022 year | 4 cases | +100 % |
2021 year | 2 cases | -80.0 % |
2020 year | 10 cases | +42.9 % |
因子 filed 116 joint applications with コーニンクレッカフィリップスエヌヴェ for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 41 cases in total) is 6.8, and the median is 7.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The highest number of filings in 2016 with 24 cases, and their lowest number in 2022 with 4 cases.
Index | Value |
---|---|
Average | 6.8 patents |
Std Dev | 3.9 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 4 cases | -42.9 % |
2021 year | 7 cases | -12.50 % |
2020 year | 8 cases | -20.00 % |
The following shows JP patents held by 因子 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 因子’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 因子 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 2 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.5 times. The most recently Invalidation Trial patent is 特許6300215 "植物の特性を増強する方法" (Invalidation Trial day 2023-02-03) , next is 特許6692856 "RNA依存性標的DNA修飾およびRNA依存性転写調節のための方法および組成物" (Invalidation Trial day 2022-02-25) .
- | No. | Title | Invalidation Trial days |
---|---|---|---|
1 | 特許6300215 | 植物の特性を増強する方法 | 2023-02-03 |
2 | 特許6692856 | RNA依存性標的DNA修飾およびRNA依存性転写調節のための方法および組成物 | 2022-02-25 |
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 6 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.3. The most invalidation trial patent is 特許5839527 "超高感度マイクロ磁気センサ" (2 times) , and the next most invalidation trial patent is 特許6300215 "植物の特性を増強する方法" (2 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許5839527 | 超高感度マイクロ磁気センサ | 2 times |
2 | 特許6300215 | 植物の特性を増強する方法 | 2 times |
3 | 特許6074462 | 抗−TNFα抗体の投与方法 | 1 times |
4 | 特許6417431 | 複数分子の抗原に繰り返し結合する抗原結合分子 | 1 times |
5 | 特許6293103 | 自己緩衝タンパク質製剤 | 1 times |
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 25 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7328390 "フィブロイン様タンパク質の製造法" (Opposition day 2024-02-15) , next is 特許7289655 "PAMPS及びDAMPSの除去への血液適合性多孔性ポリマービーズ吸着剤の使用" (Opposition day 2023-12-12) .
- | No. | Title | Opposition days |
---|---|---|---|
1 | 特許7328390 | フィブロイン様タンパク質の製造法 | 2024-02-15 |
2 | 特許7289655 | PAMPS及びDAMPSの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2023-12-12 |
3 | 特許7308329 | GABAを有効成分とするサルコペニア予防または改善剤 | 2023-10-26 |
4 | 特許7244922 | 化学修飾された一本鎖RNA編集オリゴヌクレオチド | 2023-09-20 |
5 | 特許7240388 | 熱可塑性粉末組成物及びそのような組成物の3D印刷により製造された強化三次元物体 | 2023-09-15 |
6 | 特許7231545 | 情報処理装置、クライアント装置、プログラム、及び、情報処理方法 | 2023-08-28 |
7 | 特許7162542 | 食品因子センシング関連遺伝子発現促進用食品組成物及び食品因子センシング関連遺伝子発現促進剤 | 2023-04-19 |
8 | 特許7136724 | コアセルベートを含む、乳成分非含有チーズ代替品 | 2023-03-08 |
9 | 特許7093918 | 自動車乗員のバイタルサインの非接触の検知および監視システム | 2023-01-04 |
10 | 特許7079110 | シングル丸編地 | 2022-12-01 |
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 67 patents Protest from third parties. The average number of Protest is 1.5 times. The most recently Protest patent is 再公表2020/166700 "血小板溶解物の製造方法、製造システム及びバッグセット" (Protest day 2024-03-23) , next is 特開2023-175853 "疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法" (Protest day 2024-02-16) .
- | No. | Title | Protest days |
---|---|---|---|
1 | 再公表2020/166700 | 血小板溶解物の製造方法、製造システム及びバッグセット | 2024-03-23 |
2 | 特開2023-175853 | 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法 | 2024-02-16 |
3 | 特開2022-097330 | ヤマブシタケ由来のNGF合成促進物質単離のための菌床栽培および製造方法 | 2024-01-24 |
4 | 特開2023-055917 | PAMPS及びDAMPSの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2024-01-17 |
5 | 特開2023-161047 | 育毛促進用組成物 | 2023-12-20 |
6 | 特許7419120 | 角層剥離改善剤及びそのスクリーニング方法 | 2023-11-29 |
7 | 特表2023-507637 | 鋼板表面材質検査装置及び方法 | 2023-11-15 |
8 | 特許7448640 | 撥水性布帛および繊維製品 | 2023-11-06 |
9 | 特開2023-085265 | 低粒子含有量をもつ調合物 | 2023-10-31 |
10 | 特開2020-114266 | IgG Fcドメインを有する融合タンパク質の生産方法 | 2023-10-30 |
11 | 特開2022-166844 | 土木建築材料用吸水防止材 | 2023-10-05 |
12 | 特表2021-522805 | hMPCの集団をゼノフリー生成するための方法 | 2023-07-25 |
13 | 特表2021-508663 | 合成フィロケイ酸塩を調製する方法 | 2023-05-27 |
14 | 特開2020-186503 | ポリエステル複合仮撚糸、ストレッチ性織編物、およびこれらの製造方法 | 2023-05-12 |
15 | 特許7468196 | 浴室空調装置 | 2023-04-19 |
16 | 特開2021-193379 | 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法 | 2023-04-13 |
17 | 特開2021-050215 | 皮下投与される抗IL−6受容体抗体 | 2023-03-30 |
18 | 特表2022-527809 | 抗体コード配列をセーフハーバー遺伝子座に挿入するための方法および組成物 | 2023-03-24 |
19 | 特許7328390 | フィブロイン様タンパク質の製造法 | 2023-03-24 |
20 | 特許7299573 | 清酒の劣化抑制剤、劣化が抑制された清酒及びその製造方法 | 2023-03-02 |
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 134 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.5. The most protest patent is 特許7412869 "歯肉ケア剤及びそれを含有する歯肉ケア用口腔用組成物" (5 times) , and the next most protest patent is 特許6651288 "織物" (5 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許7412869 | 歯肉ケア剤及びそれを含有する歯肉ケア用口腔用組成物 | 5 times |
2 | 特許6651288 | 織物 | 5 times |
3 | 特表2019-528113 | 機械学習モデルを使用した眼底画像の処理 | 5 times |
4 | 特許6350650 | エアバッグ用コート基布 | 4 times |
5 | 特許7132697 | 積層生地、及びその製造方法 | 4 times |
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 380 patents Inspection from third parties. The average number of Inspection is 1.2 times. The most recently Inspection patent is 再公表2020/166700 "血小板溶解物の製造方法、製造システム及びバッグセット" (Inspection day 2024-04-18) , next is 特表2023-519762 "ジスフェリン二重ベクターを用いた遺伝子治療" (Inspection day 2024-04-17) .
- | No. | Title | Inspection days |
---|---|---|---|
1 | 再公表2020/166700 | 血小板溶解物の製造方法、製造システム及びバッグセット | 2024-04-18 |
2 | 特表2023-519762 | ジスフェリン二重ベクターを用いた遺伝子治療 | 2024-04-17 |
3 | 特表2021-525362 | 多発性骨髄腫を治療すること及び4−(4−(4−(((2−(2,6−ジオキソピペリジン−3−イル)−1−オキソイソインドリン−4−イル)オキシ)メチル)ベンジル)ピペラジン−1−イル)−3−フルオロベンゾニトリルのバイオマーカーの使用 | 2024-04-12 |
4 | 特表2023-512211 | 編組された外科用インプラント | 2024-04-09 |
5 | 特開2024-045481 | IL-33アンタゴニストを含む子宮内膜症治療剤 | 2024-04-05 |
6 | 特表2021-521110 | 抗NRP2抗体を含む組成物及び方法 | 2024-03-29 |
7 | 特表2023-532569 | 抗腫瘍壊死因子受容体抗体(抗TNFR2抗体)及びその使用 | 2024-03-28 |
8 | 特許5752671 | VEGFアンタゴニスト製剤 | 2024-03-28 |
9 | 特表2023-527884 | 異常な血管新生を治療するための局所眼科用組成物および方法 | 2024-03-28 |
10 | 特許5376573 | VEGFアンタゴニスト製剤 | 2024-03-28 |
11 | 特表2021-516049 | 組換えT細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 | 2024-03-19 |
12 | 特表2021-529821 | イムノグロブリンを除去又は減少させるための遺伝子治療ベクターの形質導入を増加または増強するための組成物および方法 | 2024-03-13 |
13 | 特開2023-175853 | 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法 | 2024-03-11 |
14 | 特開2020-186503 | ポリエステル複合仮撚糸、ストレッチ性織編物、およびこれらの製造方法 | 2024-02-27 |
15 | 特開2022-081543 | 抗TREM2抗体及びその使用方法 | 2024-02-27 |
16 | 特表2021-531038 | ストレス顆粒集合を調節するためのシステム及び方法 | 2024-02-20 |
17 | 特表2023-521042 | 操作されたオリゴヌクレオチドを使用する標的化された阻害 | 2024-02-14 |
18 | 特許7233754 | 抗VEGFで処置された加齢黄斑変性症に罹患している患者の臨床転帰に遺伝変異型を関連付ける方法 | 2024-02-14 |
19 | 特表2021-500394 | αタンパク質キナーゼ1を活性化することによって免疫応答をモジュレートするための組成物および方法 | 2024-02-06 |
20 | 特許4109288 | ジアミン誘導体 | 2024-02-06 |
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 743 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.2. The most inspection patent is 特許6651288 "織物" (8 times) , and the next most inspection patent is 特開2016-144451 "より新規形態の干渉RNA分子" (7 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6651288 | 織物 | 8 times |
2 | 特開2016-144451 | より新規形態の干渉RNA分子 | 7 times |
3 | 特開2021-136968 | 認知機能の低下抑制および/または改善用組成物 | 7 times |
4 | 特開2016-155809 | 狭窄病変および血栓溶解療法のための剪断による制御放出 | 5 times |
5 | 特許6469152 | 布団側地 | 5 times |
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 3,920 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.4. The most cited patent is 特許6203410 "患者固有の解剖学的構造の画像データから冠動脈プラークの脆弱性を予測するシステム及びシステムの作動方法" (43 times) , and the next most cited patent is 特許6382724 "グローバル自動車安全システム" (42 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6203410 | 患者固有の解剖学的構造の画像データから冠動脈プラークの脆弱性を予測するシステム及びシステムの作動方法 | 43 times |
2 | 特許6382724 | グローバル自動車安全システム | 42 times |
3 | 特表2016-521975 | 遺伝的状態の処置のための方法および組成物 | 35 times |
4 | 特許6082447 | 複数分子の抗原に繰り返し結合する抗原結合分子 | 30 times |
5 | 特許6778114 | イミド系タンパク質分解モジュレーター及び関連する使用方法 | 29 times |
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International